Acetaminophen 250mg Aspirin 250mg Caffeine 65mg

Product NDC: 0363-1320
11-digit product format: 003631320
Labeler code: 0363
Product ID: 0363-1320_cbd064bd-32f1-4561-9b74-e0058a27d59a
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen 250mg Aspirin 250mg Caffeine 65mg
Dosage form: TABLET
Route: ORAL
Labeler: WALGREENS CO.
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2019-09-24
Substance: ACETAMINOPHEN; ASPIRIN; CAFFEINE
Active strength: 250; 250; 65 mg/1; mg/1; mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 4 matching rows.

View current auxiliary records. · View the auxiliary file history.

Dataset, Scope, Package NDC table
Dataset	Scope	Package NDC
excluded product	product
excluded package	package	0363-1320-23
excluded package	package	0363-1320-80
excluded package	package	0363-1320-12

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Acetaminophen 250mg Aspirin 250mg Caffeine 65mg
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ACETAMINOPHEN	250 mg/1
ASPIRIN	250 mg/1
CAFFEINE	65 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
362O9ITL9D	Internal UNII lookup
R16CO5Y76E	Internal UNII lookup
3G6A5W338E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
308297	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
98bb28ed-d146-ca3d-e053-2a95a90a9eaf	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7dea7767-9f52-b60a-5435-33cb9cc28bae	Product name	4	20250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4	Product name	7	20250116
0ca83774-3f79-b837-5d6f-c210102f3bc8	Product name	6	20250114
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
2dc76302-91c0-4c35-ad78-99adfb049c4b	Product name	1	20200603
e6065d4b-5ae1-476f-a40e-f2851cbb5d2b	Product name	2	20180221
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
332e86c3-7875-ca6e-f934-2206d2b31996	Product name	1	20140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21	Product name	1	20140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508
d223c173-c39b-d764-47d4-d671d3088815	Product name	1	20140508
e01133ad-4dcd-c7f3-454b-2ff569ee160a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
0363-1320-12	2022-04-06	Walgreens Headache Relief Geltabs Acetaminophen 250mg, Aspirin 250mg, Caffeine 65mg
0363-1320-23	2022-04-06	Walgreens Headache Relief Geltabs Acetaminophen 250mg, Aspirin 250mg, Caffeine 65mg
0363-1320-80	2022-04-06	Walgreens Headache Relief Geltabs Acetaminophen 250mg, Aspirin 250mg, Caffeine 65mg
0363-1320-12	2022-01-28	Walgreens Headache Relief Geltabs Acetaminophen 250mg, Aspirin 250mg, Caffeine 65mg
0363-1320-23	2022-01-28	Walgreens Headache Relief Geltabs Acetaminophen 250mg, Aspirin 250mg, Caffeine 65mg
0363-1320-80	2022-01-28	Walgreens Headache Relief Geltabs Acetaminophen 250mg, Aspirin 250mg, Caffeine 65mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0363-1320-12	Acetaminophen 250mg Aspirin 250mg Caffeine 65mg	120 in 1 BOTTLE	TABLET	120	5
0363-1320-23	Acetaminophen 250mg Aspirin 250mg Caffeine 65mg	20 in 1 BOTTLE	TABLET	20	5
0363-1320-80	Acetaminophen 250mg Aspirin 250mg Caffeine 65mg	80 in 1 BOTTLE	TABLET	80	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0363-1320-12	EA - Each	0363-1320	7b0882a8-9cf1-4088-b3fe-0d8f01da4000	1	2022-06-06
0363-1320-23	EA - Each	0363-1320	33b97d1a-4c50-4115-8277-b14f7d1fbe88	1	2022-06-06
0363-1320-80	EA - Each	0363-1320	bc5456cf-305d-490d-8c95-7f0ca9794f96	1	2022-06-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0363-1320	ACETAMINOPHEN 250MG ASPIRIN 250MG CAFFEINE 65MG TABLET [WALGREENS CO.]	5	Current NDC, Legacy NDC, 3 package rows	20250106_98bb28ed-d146-ca3d-e053-2a95a90a9eaf.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 53 of 79 · 1,561 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
St. Joseph Chewable Low Dose Aspirin	ASPIRIN	Foundation Consumer Healthcare LLC	248cd302-e380-4837-bdae-9df620b67e8a	2024-12-02	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	AAA Pharmaceutical, Inc.	2d98e390-4f2a-41cc-b307-3d2f6a3700dd	2024-12-02	Warnings	Exact identifier application number: M013
Acetaminophen PM	ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	AAA Pharmaceutical, Inc.	409b5fcd-5880-4dda-85d8-26aeceb4f8ab	2024-12-02	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	AAA Pharmaceutical, Inc.	c0c31523-c4c5-43c2-8d72-4d1456c720e9	2024-12-02	Warnings	Exact identifier application number: M013
NOTTS - Pain Relief PM	ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE	VIVUNT PHARMA LLC	e6754f62-e3b2-773f-e053-2a95a90ad36a	2024-12-02	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	AAA Pharmaceutical, Inc.	a891896d-c9fa-4448-915a-e6b531157d22	2024-12-02	Warnings	Exact identifier application number: M013
Pain Relief Extra Strength	ACETAMINOPHEN	SAFEWAY	d2d15e06-e9eb-3d2b-e053-2995a90a1cec	2024-12-02	Warnings	Exact identifier application number: M013
Pain Relief Regular Strength	ACETAMINOPHEN	TopCo Associates LLC	c2d33352-431c-4683-a4fa-a54437e7b8d2	2024-12-02	Warnings	Exact identifier application number: M013
Pain Relief Extra Strength	ACETAMINOPHEN	TopCo Associates LLC	bdb01b3e-ad34-4003-9b9a-e83a2c0e90bb	2024-12-02	Warnings	Exact identifier application number: M013
Aspirin 81mg Adult Low Dose	ASPIRIN	TopCare	14d010fb-c4a1-4c3d-942f-58719727bfc0	2024-12-02	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	CVS Pharmacy, Inc	c4473ee6-4e01-1ec2-e053-2995a90ac513	2024-12-02	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Proficient Rx LP	9c186289-e309-45e8-8934-1d0eae0375c2	2024-12-01	Warnings	Exact identifier application number: M013
Childrens Chewable Acetaminophen	ACETAMINOPHEN	GERI-CARE PHARMACEUTICAL CORP	22f63d62-c941-5b8f-e063-6394a90aeecd	2024-11-28	Warnings	Exact identifier application number: M013
Extra Strength Acetaminophen	ACETAMINOPHEN	Geri-Care Pharmaceutical Corp	7a7b6318-b7d6-31b1-e053-2991aa0abf25	2024-11-28	Warnings	Exact identifier application number: M013
Extra Strength Pain Reliever PM	ACETAMINOPHEN, DIPHENHYDRAMINE HCL	INGLES MARKETS, INC.	27fd288e-c07a-617f-e063-6394a90a17a4	2024-11-28	Warnings	Exact identifier application number: M013
BAYER Aspirin Original, TRAVEL BASIX	ASPIRIN	Lil' Drug Store Products, Inc.	7f5d9ebe-8119-49a2-9380-eca18a5e5e85	2024-11-27	Warnings	Exact identifier application number: M013
EXCEDRIN MIGRAINE	ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE	Jones Healthcare Group - Packaging Services, Inc	c4168e4d-3dfc-4e51-a32e-14704cb59c66	2024-11-27	Warnings	Exact identifier application number: M013
TYLENOL Extra Strength / TYLENOL Precise Cooling Pain Relief	ACETAMINOPHEN, LIDOCAINE, MENTHOL	Kenvue Brands LLC	2611e984-0dd5-bda1-e063-6394a90a559a	2024-11-26	Warnings	Exact identifier application number: M013
First Aid Only Extra-Strength Non-Aspirin	ACETAMINOPHEN	Acme United Corporation	6891d57a-10a6-53de-e053-2a91aa0ac7c2	2024-11-26	Warnings	Exact identifier application number: M013
Chewable Aspirin	ASPIRIN	MARC GLASSMAN, INC.	c8314910-71ff-5a55-e053-2995a90aafc7	2024-11-26	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN
3G6A5W338E	CAFFEINE	58-08-2	CAFFEINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308297	acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet	PSN	98bb28ed-d146-ca3d-e053-2a95a90a9eaf	5
308297	acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet	SCD	98bb28ed-d146-ca3d-e053-2a95a90a9eaf	5
308297	APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet	SY	98bb28ed-d146-ca3d-e053-2a95a90a9eaf	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0363-1320-12	00363132012	120 TABLET in 1 BOTTLE (0363-1320-12)	120 tablet	2019-09-24	0000-00-00	No	No	Current
0363-1320-23	00363132023	20 TABLET in 1 BOTTLE (0363-1320-23)	20 tablet	2019-09-24	0000-00-00	No	No	Current
0363-1320-80	00363132080	80 TABLET in 1 BOTTLE (0363-1320-80)	80 tablet	2019-09-24	0000-00-00	No	No	Current